REQUEST A DEMO
Total
USD $0.00
Search more companies

Crynssen Pharma S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Chocolate and Confectionery Manufacturing | Scientific Research and Development Services | Management of Companies and Enterprises
Full name: Crynssen Pharma S.A.S. Profile Updated: May 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Crynssen Pharma S.A.S. is based in Colombia. The head office is in Galapa. It operates in the Pharmaceutical Preparation Manufacturing sector. Crynssen Pharma S.A.S. was incorporated on July 17, 2015. There are currently 39 (2025) people employed by Crynssen Pharma S.A.S.. Its’ total assets recorded a negative growth of 6.04%.

Headquarters
Zona Franca Internacional del Atlantico
Galapa; Atlantico;

Contact Details: Purchase the Crynssen Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Crynssen Pharma S.A.S. report to view the information.
Financial Auditors:
Purchase the Crynssen Pharma S.A.S. report to view the information.
Incorporation Date:
July 17, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Crynssen Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Total Assets
-6.04%
Total Equity
24.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?